Updated results to December 2008
New Zealand experienced a prolonged epidemic of Meningococcal B disease starting in 1991 and peaking in 2001. In response, a strain-specific meningococcal B vaccine (MeNZB) was developed and offered through a national programme to all New Zealand children and teenagers under the age of 20 years from July 2004 to June 2006. MeNZB continued to be offered to babies until 1 June 2008.
This report updates findings from earlier studies assessing the impact of the MeNZB vaccine, and forms the basis of published study (Arnold R, et al. 2011. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand. Vaccine. 29(40): 7100–06).